accessibility menu, dialog, popup

UserName
Viewing profile as user:

Steroids and derivatives

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Selected Filters

Clear all

Keyword Search

glycine

Narrow Results

Narrow Results

No results found within this category. Try removing some selected filters and try again.

category

brands

  • (3)
  • (1)
1 – 4 of 4 results
1

Medchemexpress LLC Glycine-2,2-d2, n-(1-oxobutyl)- | 1219799-10-6 | 99.2% | 147.17 g/mol | C6H9D2NO3 | 5 MG

N-Butyrylglycine-d2 is the deuterium-labeled form of N-butyrylglycine intended for laboratory research. It is provided as a high-purity isotopically labeled standard for use in analytical, tracer, and metabolic studies. The material is supplied with supporting analytical documentation and is for research use only.

  • Deuterium-labeled (d2) isotopologue.
  • High purity: 99.2% (nominal).
  • Verified molecular weight: 147.17 g/mol.
  • Chemical formula C6H9D2NO3.
  • Certificates available: COA, HNMR, RP-HPLC, SDS.
  • Available in small mg pack sizes suitable for analytical use.

ENCOMPASS_PREFERRED
2

Cayman Chemical GlycocholIc AcId 5g

A glycine-conjugated form of cholic acid; has roles in the emulsification of fats; reduces expression of the gene encoding FXR and increases expression of the genes encoding the bile acid receptors TGR5 and S1PR2 in SNU-245 cells at 1.6 μmol/ml; increases the intracellular accumulation and cytotoxicity of epirubicin in Caco-2 cells at 250 μM, as well as decreases expression of the genes encoding MDR1, MRP1, and MRP2 when used alone or in combination with epirubicin; increases absorption of epirubicin into everted sacs of rat ileum and jejunum at 250 μM; bile acid composition ratio of glycocholic acid is elevated in bile of patients with cholangiocarcinoma compared with patients with pancreatic cancer or benign biliary diseases; serum levels are elevated in patients with hepatocellular carcinoma compared with healthy individuals

ENCOMPASS_PREFERRED
3

Cayman Chemical GlycocholIc AcId 10g

A glycine-conjugated form of cholic acid; has roles in the emulsification of fats; reduces expression of the gene encoding FXR and increases expression of the genes encoding the bile acid receptors TGR5 and S1PR2 in SNU-245 cells at 1.6 μmol/ml; increases the intracellular accumulation and cytotoxicity of epirubicin in Caco-2 cells at 250 μM, as well as decreases expression of the genes encoding MDR1, MRP1, and MRP2 when used alone or in combination with epirubicin; increases absorption of epirubicin into everted sacs of rat ileum and jejunum at 250 μM; bile acid composition ratio of glycocholic acid is elevated in bile of patients with cholangiocarcinoma compared with patients with pancreatic cancer or benign biliary diseases; serum levels are elevated in patients with hepatocellular carcinoma compared with healthy individuals

ENCOMPASS_PREFERRED
4

Cayman Chemical GlycocholIc AcId 1g

A glycine-conjugated form of cholic acid; has roles in the emulsification of fats; reduces expression of the gene encoding FXR and increases expression of the genes encoding the bile acid receptors TGR5 and S1PR2 in SNU-245 cells at 1.6 μmol/ml; increases the intracellular accumulation and cytotoxicity of epirubicin in Caco-2 cells at 250 μM, as well as decreases expression of the genes encoding MDR1, MRP1, and MRP2 when used alone or in combination with epirubicin; increases absorption of epirubicin into everted sacs of rat ileum and jejunum at 250 μM; bile acid composition ratio of glycocholic acid is elevated in bile of patients with cholangiocarcinoma compared with patients with pancreatic cancer or benign biliary diseases; serum levels are elevated in patients with hepatocellular carcinoma compared with healthy individuals

ENCOMPASS_PREFERRED